James Stodder and Houman Younessi - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

James Stodder and Houman Younessi

Description:

See (1) www.merck.com/merckhelps/ , (2) www.pfizerhelpfulanswers.com/pages ... Automobiles. Software, Movies, Textbooks! Consumer Electronics. Pharmaceuticals ... – PowerPoint PPT presentation

Number of Views:18
Avg rating:3.0/5.0
Slides: 33
Provided by: JamesS112
Category:

less

Transcript and Presenter's Notes

Title: James Stodder and Houman Younessi


1
Transparency and Credible Commitment Most-Favore
d-Customer Price Differentiation www.ewp.rpi.edu/
hartford/stodder/PriceDisc.ppt
James Stodder and Houman Younessi Lally School of
Management Technology Rensselaer Polytechnic
Institute at Hartford Hartford, Connecticut, USA
2
Separable Markets 3rd Degree Price
Discrimination
  • Domestic Examples
  • Airline Tickets
  • Starbucks Prices, Different Cities
  • Student, Senior Discounts for Movies
  • Dry Cleaning for Men and Women
  • College Scholarships
  • Pharmaceuticals
  • See (1) www.merck.com/merckhelps/ ,
  • (2) www.pfizerhelpfulanswers.com/pages/Find
    /findall.aspx

3
International Price Discrimination
  • Examples
  • Starbucks Coffee
  • Automobiles
  • Software, Movies, Textbooks!
  • Consumer Electronics
  • Pharmaceuticals
  • (1) www.merck.com/cr/enabling_access/developing_w
    orld/

4
For Successful Price Discrimination, One Needs
  • Price-Setting Power
  • Differing Price Sensitivities
  • Barriers to Resale, can be
  • Practical (hard to re-sell your senior discount
    meal), or
  • Legal (Big Pharma attempts to prohibit
    re-importation, a.k.a, parallel trade)

5
A Well-Known Device to Combat Reselling
  • Sell to the public at Single (High) Price, but
    then
  • Give each customer a different Lump-Sum Rebate
    i.e., one that cannot be changed by the amount
    purchased (e.g., based on the customers past
    income).
  • To be profitable, reselling must now be Above
    Original Price so it doesnt happen.

6
However, in solving One Problem, the Lump-Sum
Rebate gives Rise to Another Problem
  • Larger Customers will now try to Re-Negotiate
    Larger Rebates e.g., reference pricing.
  • How can a Company defend against such pressures?

7
Patricia Danzon (Wharton) idea on How to Prevent
Re-negotiation
  • Keep Lump-sum Rebates Secret
  • But how good are Governments at keeping other
    secrets?

8
Consider a common device to defend a single
(monopolistic) price
  • A Most-Favored-Customer (MFC) Clause
  • Any Discount given to one customer must be given
    to All MFCs.
  • A MFC Clause makes highly credible the sellers
    promise to not renegotiate prices since to do
    so would be very expensive.

9
Most-Favored-Customer (MFC)
Price Differentiation (PD)
MFCPD
  • Our idea is that the non-negotiable credibility
    of MFC can add transparency to PD to create
    MFCPD.
  • Customers are most-favored in the sense that they
    see no one gets a better formula for their
    income-based rebate even though they have
    different incomes.
  • Giving a better formula to anyone would mean
    giving that same formula to all with a big
    impact on profits.

10
Derivation Linear Demand Function
  • Demand for quantity Qi from segment i
  • Qi Popia ßPi ?Yi
  • where Popi is Population, Pi is Price,
  • Yi is income to group i,
  • and a, ß, ? are Market Parameters
  • to be Estimated.

11
Profit Maximizing Price for group i
  • If Marginal Cost µ, then Comapany Profits from
    group i
  • p i (Pi µ)Q i
  • (Pi µ)Popia ?Yi ßPi
  • First Order Condition for Profit Max
  • Published Formula for Price After Rebate
  • Pi (a ?Yi µß)/2ß

12
Full Incentive Compatibility
  • A MFCPD clause is fully incentive compatible
    i.e., will stop the Company from allowing a
    price-cut with group i (which costs it ?pi , even
    though it avoids threatened ? )
  • when the resulting decrease in profits from all
    other groups ? j?i ?pj is so large that
  • ?pi ? j?i ?pj gt ?
  • from asked-for from lower price
    from threat of curtailed
  • lower price by i impact on all j ? i
    purchases by i

13
To overcome Incentive Compatibility for the
Company (reverse the inequality) Group i would
need a Very Large Threat Multiplier (ti)
  • ?pi ? j?i ?pj lt ?
  • then, dividing by ?pi, we have
  • 0 lt 1 (? j?i ?pj) /?pi lt ? /?pi ti
  • Effective Threat Multiplier

14
Size of the Threat Multiplier
  • Even for the largest economy (US), ti is still
    substantial.
  • In our simulation of country-based price
    discrimination, US accounts for 38 of all
    Company profits.
  • 1 (? j?i ?pj)/?pi lt /?pi ti
  • 1 (62 / 38) 2.63 lt /?pi ti

15
Finer Price Disc gt
Less Non-Linearity gt
More Stable Threat Multiplier
16
Effective Threat to Companys Profits Implies a
Proportional Threat to Group is Own Surplus
  • If group is demand is linear, we show that its
    hoped-for gain in consumer surplus, ??i, if
    backed up by threat multiplier ti
  • poses a proportional threat to its own surplus
  • gt ti ?pi gt gt ti ??i

17
No-Negotiation is Sub-Game Perfect
18
No-Negotiation is Sub-Game Perfect
19
No-Negotiation is Sub-Game Perfect
20
No-Negotiation is Sub-Game Perfect
21
No-Negotiation is Sub-Game Perfect
22
What about Imperfect Knowledge? Sub-Game Perf.
Eq. does not apply.
Call pi group is subjective probability of the
Company eventually acceding to its threat. Then
risk-neutral i should make threat if and only if
pi ??i (1- pi) ti (-??i) gt 0 gt pi gt (1-
pi) ti, and ti gt 2.66 gt pi /(1- pi) gt ti gt
2.66 gt pi gt 72.7
23
Summary of Simulation Results
24
World Monopoly Price Few Countries Can Purchase
25
(No Transcript)
26
(No Transcript)
27
(No Transcript)
28
(No Transcript)
29
(No Transcript)
30
(No Transcript)
31
(No Transcript)
32
Pharma Futures Report (www.pharmafutures.org)
  • Challenge 7 To Respond Appropriately to Demands
    for More Equitable and Extensive Access to
    Medicines
  • As emerging markets become more commercially
    interesting they pose a two-pronged challenge to
    the industry, which requires a significantly
    different management skill set from those needed
    in industrialised markets.
  • The first prong requires industry to develop a
    pricing policy that captures not only the premium
    markets but permits an extension of volume sales
    to a wider customer base. And this must be
    achieved while simultaneously preventing negative
    impacts such as reference pricing or
    inappropriate parallel trade in established
    markets.
  • The second prong is to respond to demand for
    access to medicines in these markets (and in
    countries that are less commercially promising)
    in such a way as to defend the industrys
    commercial interests while at the same time
    persuading key decision makers that the response
    is sufficient to overcome mistrust, minimize
    criticism and extend licence to operate.
Write a Comment
User Comments (0)
About PowerShow.com